tirzepatide lawsuits Lilly files more to curb sales of counterfeit Mounjaro Novo Nordisk Seeks Injunction Against

Cancer-treatment-induced neurotoxicityfocus on newer treatments

What does the research on GLP-1 drugs and quitting smoking show

Beyond Weight Loss: Metabolic Improvements Participants also saw improvements in cardiometabolic health markers: Blood pressure: Systolic BP decreased by 7.4 mmHg Triglycerides: Fell by 30% HDL cholesterol: Increased by 8% (the "good" cholesterol) Liver fat: Reduced by 50% based on imaging studies HbA1c: Decreased by 0.4% even in participants without diabetes Visceral fat: Reduced by 42% (more than total weight loss percentage) Some of these improvements (particularly the visceral and liver fat reductions) are larger than the overall weight loss, which points to direct metabolic effects from the glucagon receptor activation

For most healthy adults with a qualified provider, yes